Invokana Lawsuit Plaintiff Alleges Janssen Failed To Warn About Side Effects

May 15, 2016 – – TheProductLawyers.com reports on Invokana and a Canadian lawsuit, filed in September 2015 against Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson Corporation, that links it to dangerous and life-threatening side effects related to renal impairment and kidney failure. In light of lawsuits filed by other diabetes patients in the United States, the Canadian lawsuit has been given class action status. The plaintiff is suing for more than $1 billion in damages which she states is on behalf of numerous other patients like herself that have been adversely and unnecessarily impacted by using the drug to treat their type-2 diabetes in that they all were alleged to have suffered serious and dangerous side effects after taking it.

According to court documents the plaintiff was given the U.S. Food and Drug Administration (FDA) approved Invokana, a sodium glucose cotransporter-2 (SGLT2) inhibitor drug, in 2014 to treat her type-2 diabetes to assist her in maintaining her blood glucose (sugar) levels. The drug prevents the kidneys from reabsorbing excess sugar and disposes of it instead through the use of the kidneys via urination, thus placing an extra burden on the organs. After seeing reports of other patients developing potentially fatal kidney failure, the plaintiff had her doctor run some tests and she was later diagnosed with kidney failure. She states that she was never made aware of this risk of developing kidney failure and would never have used the drug if she had known of such risks prior to taking the drug.

Additionally, and as stated in the plaintiff’s court documents, it is alleged that Janssen did not adequately and fully conduct sufficient studies to better determine the drug’s impact on the kidneys. The plaintiff also believes that Janssen Pharmaceuticals did not provide the proper product label warnings about the potentially life-threatening side effects of Invokana and the other SGLT2 inhibitor class drugs.

For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009964